Teplizumab Preserves C-Peptide in Recent-Onset Type 1 Diabetes Two-Year Results From the Randomized, Placebo-Controlled Protégé Trial

Overview of attention for article published in Diabetes, October 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

news: 2 news outlets
patent: 4 patents

f1000: 1 research highlight platform

Citations

dimensions_citation: 202 Dimensions

Readers on

mendeley: 137 Mendeley

Summary News Patents Research highlights Dimensions citations

So far, Altmetric has seen 1 review on a research highlight platform.

Recommended in Faculty Opinions

30 Jul 2013

This research output was recommended by a member of Faculty Opinions.

This page shows the most recent research highlights that mention this research output.

Click here to find out how to access more activity.